[Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome]

Area of Science:

• Cardiology
• Endocrinology
• Nephrology
• Internal Medicine
• Diabetes Management

Background:

• Metabolic syndrome, a cluster of metabolic alterations, shows high prevalence in Latin America.
• The concept of metabolic syndrome is debated but considered a useful nosographic entity in the region.
• Patients with diabetes, hypertension, and comorbidities represent a high-risk, often underestimated population.

Purpose of the Study:

• To provide a guide for physicians managing patients with diabetes, hypertension, and related comorbidities in Latin America.
• To raise awareness among physicians regarding the high-risk population associated with metabolic syndrome.
• To offer updated recommendations based on expert consensus.

Main Methods:

• Development of guidelines by a multidisciplinary expert panel from Latin American medical societies.
• Consensus reached through presentations and debates during a 2-day conference in Bucaramanga, October 2012.
• Recommendations approved by all participants.

Main Results:

• The document emphasizes the clinical utility of recognizing metabolic syndrome in Latin America.
• Identifies a specific high-risk patient population requiring focused medical attention.
• Provides a framework for diagnosis and treatment strategies.

Conclusions:

• Physicians should pay particular attention to metabolic syndrome in patients with diabetes and hypertension.
• Effective management requires addressing comorbidities and complications associated with these conditions.
• Further interventions are needed to ensure adherence to guideline recommendations by both physicians and patients.